Dr. Mark Kockx, co-founder of HistoGeneX Laboratories, was an internationally recognized pathologist-scientist whose pioneering work in biomarker analysis and personalized medicine helped shape the scientific mission that guides CellCarta today, and his contributions to cancer research have left a lasting mark on the field. As a devoted mentor and generous collaborator, Mark placed his colleagues, students, and patients at the heart of everything he did.